Early targeted patent ductus arteriosus treatment in premature neonates using a risk based severity score: study protocol for a randomised controlled trial (PDA RCT) [version 1; peer review: 2 approved]
A patent ductus arteriosus (PDA) in preterm infants is associated with increased ventilator dependence and chronic lung disease, necrotizing enterocolitis, intraventricular haemorrhage, and poor neurodevelopmental outcome. Randomised controlled trials of early PDA treatment have not established a dr...
Main Authors: | Afif EL-Khuffash, Neidin Bussmann, Colm R. Breatnach, Aisling Smith, Elizabeth Tully, Joanna Griffin, Naomi McCallion, John David Corcoran, Elena Fernandez, Claudia Looi, Brian Cleary, Orla Franklin, Patrick J. McNamara |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-11-01
|
Series: | HRB Open Research |
Online Access: | https://hrbopenresearch.org/articles/3-87/v1 |
Similar Items
-
Patent Ductus Arteriosus Clinical Trials: Lessons Learned and Future Directions
by: Aisling Smith, et al.
Published: (2021-01-01) -
Diameter of the ductus arteriosus as a predictor of patent ductus arteriosus (PDA)
by: Nowak Dariusz, et al.
Published: (2011-08-01) -
Prenatal prediction of neonatal haemodynamic adaptation after maternal hyperoxygenation
by: Ann McHugh, et al.
Published: (2020-11-01) -
The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1): study protocol and review of literature
by: Afif EL-Khuffash, et al.
Published: (2018-12-01) -
Circulatory Insufficiency and Hypotension Related to the Ductus Arteriosus in Neonates
by: Danielle R. Rios, et al.
Published: (2018-03-01)